DEF 14A Filing

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 26, 2019

Period of Report

June 14, 2019

Accession Number

0000930413-19-001350

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →